Welcome to our dedicated page for Alphatec Hldgs SEC filings (Ticker: ATEC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Alphatec Holdings, Inc. filings document the reporting record of a spine-focused medical technology company. Its Form 8-K disclosures include quarterly and annual operating results, surgical and EOS revenue commentary, non-GAAP profitability measures, preliminary financial information and related press-release exhibits.
The company’s regulatory filings also cover material financing agreements, including senior secured credit facilities, revolving borrowing capacity, term-loan arrangements and references to convertible senior notes. Proxy and governance filings document director elections, board composition, executive and director compensation, equity awards, committee matters and other shareholder voting disclosures.
ATEC submitted a Form 144 notice reporting a proposed sale of 19,900 shares by Scott Lish. The filing shows the sale date 12/16/2025 and aggregate proceeds of $389,964.35. The excerpt also lists multiple issuer-issued performance stock units and restricted stock vesting entries with dates and share counts.
Issuer submitted a Form 144 disclosing proposed or planned sales of Common stock and recent 10b5-1 activity by an affiliate. The filing lists 112,894 Performance Stock Units and 50,558 Restricted Stock Units, each dated 03/05/2026.
The filing also records 10b5-1 sales by David Sponsel of 60,425 Common shares on 02/05/2026 for $833,162.03.
Alphatec Holdings EVP Craig E. Hunsaker reported open-market sales of 116,367 shares of common stock at weighted average prices around $12.22 and $12.45 per share. These sales were carried out under a Rule 10b5-1 trading plan adopted to satisfy tax withholding obligations from vesting restricted stock units.
He also made a bona fide gift of 600 shares. After these transactions, Hunsaker directly holds 1,725,609 shares of Alphatec common stock, indicating the activity represents a relatively small portion of his overall stake and appears primarily tax- and planning-related.
Alphatec Holdings, Inc. chief financial officer John Todd Koning reported a tax-related share disposition. On March 5, 2026, 68,910 shares of common stock at $12.57 per share were withheld by the company to cover his tax obligations from vesting restricted stock units.
After this withholding transaction, Koning continued to hold 680,510 shares of Alphatec Holdings common stock in direct ownership.
Alphatec Holdings, Inc. CEO Miles Patrick reported a tax-related share disposition. On March 5, 2026, he disposed of 219,749 shares of Common Stock at $12.57 per share through a Form 4 transaction coded “F.”
The footnote explains these shares were withheld by the issuer to satisfy tax withholding obligations arising from the vesting of restricted stock units, rather than an open-market sale. After this transaction, Patrick directly owned 5,778,551 shares, and indirectly held 10,900 shares by IRA and 250,000 shares by MOM, LLC.
Alphatec Holdings, Inc. reported that its General Counsel and Corporate Secretary, Marshall Tyson Eliot, sold 88,835 shares of common stock in an open-market transaction at a weighted average price of $12.49 per share on March 5, 2026.
These sales were effected under a pre-arranged Rule 10b5-1 trading plan adopted on March 14, 2025 to cover tax withholding obligations arising from the vesting of restricted stock units. Following this sale, Eliot directly holds 559,459 shares of Alphatec common stock.
Craig Hunsaker reported insider sales. The filing shows 66,041 RSUs and 162,665 PSUs were sold to cover with trade dates listed as 03/05/2026 and an execution/settlement date of 03/06/2026. It also lists a prior sale of 32,584 common shares on 12/10/2025. The broker is shown as Merrill Lynch.
Issuer submitted a Form 144 notice reporting proposed sales of equity-linked awards by an affiliated holder. The filing lists 31,916 Restricted Stock Units and 56,919 Performance Stock Units, each dated 03/05/2026.
The filing is a routine Rule 144 notice of intended sale under resale restrictions and does not by itself consummate transactions.
Alphatec Holdings, Inc. announced that longtime director Ward W. Woods chose to retire from its Board of Directors, effective February 27, 2026, for personal reasons. The company states his departure is not due to any disagreement regarding its operations, policies, or practices.
Mr. Woods, who also served on the Board’s Compensation Committee, entered into a Vesting Acceleration Agreement with Alphatec. Under this agreement, any restricted stock units granted to him on June 11, 2025 that remain unvested on his departure date will become fully vested. Following his resignation, the Board reduced its size from eight to seven directors to match the new composition.
Marshall Tyson Eliot reported acquisition or exercise transactions in this Form 4 filing.
Alphatec Holdings reported that its General Counsel and Corporate Secretary, Marshall Tyson Eliot, received multiple equity awards on February 25, 2026. He was granted 205,094 restricted stock units (RSUs) tied to a prior performance-based award for the fiscal year ended December 31, 2025, vesting in three annual installments starting March 5, 2026.
He also received 84,918 RSUs vesting annually from March 5, 2027 through March 5, 2029, and 12,840 RSUs granted in lieu of a portion of his 2025 cash bonus, vesting on December 4, 2026. In addition, he was granted an award of up to 42,459 performance-based RSUs that vest only if specified stock price or operational metrics are achieved by dates running through December 31, 2030. Related common stock awards increased his directly held common shares to 648,294 at no cash cost to him.